Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation Thirty probands were enrolled ...
Lead, South Dakota--(Newsfile Corp. - December 18, 2025) - Dakota Gold Corp. (NYSE American: DC) ("Dakota Gold" or the "Company") is providing an update on the metallurgical testing program (the "Met ...
Mainz Biomed N.V. has announced the next phase in its PancAlert project, which aims to develop a non-invasive blood test for early pancreatic cancer detection. Following a successful discovery ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
VANCOUVER, BC, April 14, 2025 /CNW/ - Freeman Gold Corp. (FMAN:CA) (OTCQB: FMANF) (FSE: 3WU) ("Freeman" or the "Company") is pleased to announce that it has awarded the Feasibility metallurgical test ...